Identification of Novel Antagonists Targeting Cannabinoid Receptor 2 Using a Multi-Step Virtual Screening Strategy
The endocannabinoid system plays an essential role in the regulation of analgesia and human immunity, and Cannabinoid Receptor 2 (CB2) has been proved to be an ideal target for the treatment of liver diseases and some cancers. In this study, we identified CB2 antagonists using a three-step “deep lea...
Guardado en:
Autores principales: | Mukuo Wang, Shujing Hou, Ye Liu, Dongmei Li, Jianping Lin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5d2110cbb9644b1e972d0bfd4cd9f7ab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Discovery of novel potential KIT inhibitors for the treatment of gastrointestinal stromal tumor
por: Jiang Lili, et al.
Publicado: (2021) -
Structure based prediction of a novel GPR120 antagonist based on pharmacophore screening and molecular dynamics simulations
por: Ajay Pal, et al.
Publicado: (2021) -
<i>In Silico</i> Screening of Semi-Synthesized Compounds as Potential Inhibitors for SARS-CoV-2 Papain-like Protease: Pharmacophoric Features, Molecular Docking, ADMET, Toxicity and DFT Studies
por: Mohamed S. Alesawy, et al.
Publicado: (2021) -
Virtual Screening for Potential Phytobioactives as Therapeutic Leads to Inhibit NQO1 for Selective Anticancer Therapy
por: Bhargav Shreevatsa, et al.
Publicado: (2021) -
Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists
por: Parthasaradhireddy Tanguturi, et al.
Publicado: (2021)